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Most patients with Prader-Willi syndrome have a
deletion of 15q11 - 1 3 or maternal uniparental disomy
for chromosome 15. The shortest region of deletion
overlap is presently defined by the gene for the small
nuclear ribonucleoprotein N (SNRPN). We have
investigated the integrity of SNRPN as well as the
methylation status of D15S63 (PW71) in two patients
with apparently normal chromosomes 15 of biparental
origin. SNRPN is normal in one patient and deleted in
the other one. Both patients are intact at the D15S63
locus, but have an abnormal methylation pattern. These
results suggest that a DNA sequence close to SNRPN
determines the methylation status of D15S63 and that
the methylation test does not only detect the common
deletions and uniparental disomy, but other rare lesions
as well.
INTRODUCTION
Prader-Willi syndrome (PWS) and Angelman syndrome (AS)
are distinct neurogenetic diseases. Approximately 70% of patients
with PWS have a paternally derived deletion of 15ql 1 —13. Thirty
per cent of patients lack a paternal chromosome 15 and have two
maternal copies (uniparental disomy, UPD). These findings
suggest that the gene(s) affected in PWS are expressed from the
paternal chromsome 15 only. Reciprocal findings in AS indicate
that the AS gene(s) are expressed from the maternal chromosome
only (for review see reference 1). The mechanisms underlying
parent-of-origin specific gene expression (imprinting) are
unknown, but DNA methylation may play a major role in this
process (2—6).
Deletions in PWS and AS typically affect a region of 4 - 5 Mb,
which includes the loci D15S9, D15S11, D15S13, D15S63,
SNRPN, D15S10, D15S113, GABRB3, D15S97, GABRA5,
D15S78 and D15S12 (7). Recently, we have identified a pair
of PWS sibs (family S) who have a deletion of less than 300 kb
(8). The deletion encompasses the gene for the small nuclear
ribonucleoprotein N (SNRPN), which is active on the paternal
chromosome 15 only (6), but none of the other marker loci in
the region. Interestingly, these patients and another pair of PWS
sibs (family O), who have apparently normal chromosomes of
biparental inheritance, have an aberrant DNA methylation pattern
at the D15S63 (PW71) locus (8), which maps 130 kb proximal
to SNRPN (10). Modification of the methylation pattern at this
locus and at the D15S9 (ML34) locus was observed in some AS
patients also (5,8). Here we have investigated the integrity of
SNRPN and the methylation status of D15S63 and D15S9 in two
other PWS patients who by standard microsatellite analysis were
found to have apparently normal chromosomes of biparental
origin.
RESULTS AND DISCUSSION
Two patients with typical PWS were studied with microsatellites
from 15ql 1 — 13 (Table 1). Patient S12 is heterozygous at the
D15S11, D15S113 and D15S97 loci and, therefore, does not have
a typical deletion. Uniparental disomy was excluded by the
observation of maternal and paternal alleles at D15S113 and
D15S97. The presence of biparental alleles at four loci in patient
14-3 rules out a typical deletion and uniparental disomy in this
patient also.
The integrity of the SNRPN gene was tested by quantitative
Southern blot analysis of BglR + Cfol digested DNA. As shown
in Fig. la, the probe SmN\ identifies a 7.5 kb band from the
SNRPNP1 pseudogene on chromosome 6 and a 5.8 kb band from
the SNRPN locus on chromosome 15 (9,10, and unpublished
results). Patient S12 has a 5.8 kb band of normal intensity,
whereas 14-3 has a 5.8 kb band of reduced intensity. Similar
results were obtained in one other independent experiment (not
shown). This indicates that patient S12 is intact for SNRPN and
that patient 14-3 is deleted.
Note that the faint 5.0 kb band from the SNRPN locus is
missing in the AS control (Fig. la). Similar results were obtained
in three other AS deletion patients and two AS UPD patients (not
shown). The difference appears to be due to parent-of-origin
specific partial methylation of a Cfol site within the SNRPN gene
(6) and may be employed for diagnostic testing of patients
suspected of having AS. It cannot be used for diagnosing PWS,
because the PWS pattern is indistinguishable from the normal
pattern.
Next we determined the integrity and the methylation status
of D15S63. Quantitative Southern blot analysis of HindUl
digested DNA with PW71 revealed a 6.6 kb band of normal
intensity in both patients (Fig. lb). The methylation status was
determined by hybridization of a HindUl + HpaU blot and a
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Figure 1. Southern blot analysis of patients S12, 14-3, a PWS deletion patient
(PWS del), an AS deletion patient (AS del) and a normal control, mat, maternal;
pat, paternal, (a) DNA from peripheral blood was digested with BglQ + Cfol
and probed with SmNl (SNRPN). Signal intensities were determined with a
Shimadzu Densitometer C9000. The normalized hybridization ratios
SNRPN/SNRPNP1 are given underneath each lane. Patient S12 has a 5.8 kb
SNRPN band of normal intensity, whereas patients 14-3, AS del and PWS del
have a 5.8 kb SNRPN band of reduced intensity. The AS patient lacks the 5.0
kb SNRPN band. The identity of the 4.5 kb band is unknown, (b) DNA samples
were digested with Hindm and probed with PW71B (4). After stripping, the blots
were rehybridized with a probe for METD, which maps to chromosome 7. The
normalized hybridization ratios PW71/METD are given underneath each lane.
Patients SI2 and 14-3 have a PW71 band of normal intensity, whereas PWS del
has a PW71 band of reduced intensity, (c) DNA samples were digested with BglB
+ Cfol and probed with PW71B (4). The 8.0 kb band and the 6.4 kb band represent
the maternal and the paternal methylation imprint, respectively. Patients S12,
14-3 and PWS del lack the 6.4 kb band. Patient AS del lacks the 8.0 kb band.
Lane S12 is slightly overloaded, (d) DNA samples were digested with HiniSQ
+ HpaU and hybridized with ML34 (2). The 6.0 kb band and the 2.8 kb band
represent the maternal and the paternal methylation imprint, respectively. Patients
S12 and 14-3 appear to have a normal pattern, although we cannot rule out slight
quantitative differences. Patient AS del lacks the 6.0 kb band, whereas patient
PWS del lacks the 2.8 kb band.
BglU + Cfol blot. Both patients lack the 4.7 kb Hin<SIl + HpaU
band (not shown) and the 6.4 kb BglU + Cfol band (Fig. lc).
These results indicate that in the two patients the HpaU site and
the Cfol site which normally are methylated on the maternal
chromosome only (4) are methylated on the maternal and the
paternal chromosome 15.
It is unclear why the SNRPN deletion in patient 14-3 and in
the PWS siblings described by Reis et al. (8) modified the
methylation imprint on the paternal chromosome. It is possible
that the deletion includes a regulatory sequence which directly
or indirectly determines the methylation status of the D15S63
locus. An as yet unidentified deletion or mutation of this sequence
may be the cause of aberrant DNA methylation in patient S12
and in the non-deletion PWS siblings described by Reis et al.
(8). It is tempting to speculate that this sequence controls the
imprinting process in 15q l l -q l3 .
Methylation of D15S9 (ML34) was tested with HindlR +
HpaU blots. As shown in Fig. Id, apparently normal patterns
were observed in both patients. Similar findings were made in
a PWS patient, who has a large deletion (B.Horsthemke et al.,
unpublished), as well as in the PWS siblings deleted for SNRPN
only (family S; 8). Although it is possible that there are slight
quantitative differences in the methylation patterns, the results
suggest that ML34 methylation is less reliable for diagnostic
testing.
The patients described by Reis et al. (8) and in this report
demonstrate that microsatellite analysis based on the commonly
used markers in 15qll —13 fails to detect some patients with
PWS. This is in contrast to the PW71 methylation test, which
not only detects the typical deletions and uniparental disomy (3),
but other lesions also. In fact, we are not aware of any typical
PWS patient with normal D15S63 methylation.
Although the methylation test is the only test that detects both
deletion and non-deletion PWS, it does not distinguish between
the two, unless the relative intensity of the hybridization signals
is determined. This can easily be done by rehybridization of BglU
+ Cfol blots with a SNRPN probe, because the SNRPNP1 signal
from chromosome 6 can serve as an internal standard to determine
the copy number of PW71 and SNRPN.
The combined PW71 /SNRPN test is the method of choice for
rapid diagnostic testing of patients suspected of having PWS.
Furthermore, it detects lesions which are undetectable by any
other technique. However, the test does not provide any
information on the nature and extent of a deletion. Neither does
it distinguish between uniparental disomy or normal chromosomes
of biparental origin (such as patient SI2). This information can
be obtained only by additional tests such as cytogenetic and
microsatellite analysis. Specific knowledge about the etiology of
PWS in a given patient is important for accurate estimates about
the recurrence risk.
MATERIALS AND METHODS
Patients
Patient 14-3 is from Israel, male and 18 years old. Patient SI2 is from Spain,
male and 5 years old. Both patients had severe hypotonia in early infancy and
developed hyperphagia and obesity in early childhood. They have cryptorchidism,
short stature, characteristic face and mental retardation. Their family history is
unremarkable. The father of patient 14-3 is deceased and could not be studied.
DNA analysis
DNA from peripheral blood was digested with BglU + Cfol and hybridized with
SmNl (SNRPN; 10) and PW71B (D15S63; 4). For determining the copy number
of PW71, Hin&W digested DNA was hybridized with PW71B. After stripping,
the blots were rehybridized with a probe for METD, which maps to chromosome
7. Relative signal intensities were determined with a Shimadzu Densitometer
C9000. Windni + HpaU blots were used to determine the methylation status at
the ML34 locus (2). Microsatellite analysis was performed as described before
(8,11,12).
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